Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

390 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Allocation concealment and blinding: when ignorance is bliss.
Forder PM, Gebski VJ, Keech AC. Forder PM, et al. Among authors: gebski vj. Med J Aust. 2005 Jan 17;182(2):87-9. doi: 10.5694/j.1326-5377.2005.tb06584.x. Med J Aust. 2005. PMID: 15651970 Review. No abstract available.
Dose intensity in anthracycline-based chemotherapy for metastatic breast cancer: mature results of the randomised clinical trial ANZ 9311.
Ackland SP, Gebski V, Zdenkowski N, Wilson A, Green M, Tees S, Dhillon H, Van Hazel G, Levi J, Simes RJ, Forbes JF, Coates AS; for Breast Cancer Trials Ltd (formerly known as the Australia and New Zealand Breast Cancer Trials Group). Ackland SP, et al. Breast Cancer Res Treat. 2019 Jul;176(2):357-365. doi: 10.1007/s10549-019-05187-y. Epub 2019 Apr 26. Breast Cancer Res Treat. 2019. PMID: 31028610 Clinical Trial.
Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP).
Grimison PS, Stockler MR, Chatfield M, Thomson DB, Gebski V, Friedlander M, Boland AL, Houghton B, Gurney H, Rosenthal M, Singhal N, Kichenadasse G, Wong SS, Lewis CR, Vasey PA, Toner GC; Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Grimison PS, et al. Ann Oncol. 2014 Jan;25(1):143-8. doi: 10.1093/annonc/mdt369. Ann Oncol. 2014. PMID: 24356625 Free article. Clinical Trial.
Single-Agent High-Dose Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Human Leukocyte Antigen-Matched Reduced-Intensity Peripheral Blood Stem Cell Transplantation Results in an Unacceptably High Rate of Severe Acute Graft-versus-Host Disease.
Bradstock KF, Bilmon I, Kwan J, Micklethwaite K, Blyth E, Deren S, Bayley A, Gebski V, Gottlieb D. Bradstock KF, et al. Biol Blood Marrow Transplant. 2015 May;21(5):941-4. doi: 10.1016/j.bbmt.2015.01.020. Epub 2015 Jan 27. Biol Blood Marrow Transplant. 2015. PMID: 25636379 Free article. Clinical Trial.
390 results